Literature DB >> 22174285

Identification of cell cycle-regulated, putative hyphal genes in Candida albicans.

Raluca Gordân1, Saumyadipta Pyne, Martha L Bulyk.   

Abstract

Candida albicans, a major fungal pathogen in human, can grow in a variety of morphological forms ranging from budding yeast to pseudohyphae and hyphae, and its ability to transition to true hyphae is critical for virulence in various types of C. albicans infections. Here, we identify 17 putative hyphal genes whose expression peaks during the S/G2 transition of the cell cycle in C. albicans . These genes are Candida-specific (i.e., they do not have orthologs in S.cerevisiae, a related fungal species that does not exhibit hyphal growth and is primarily non-pathogenic), and their promoters are enriched for the DNA binding site motifs of Tec1 and Rfg1, two transcription factors (TFs) known to play important roles in hyphal growth and virulence. For 5 of the 17 genes we found strong evidence in the literature that confirms our hypothesis that these genes are involved in hyphal growth and/or virulence, for 5 additional genes we found suggestive (albeit weak) evidence, while the other genes remain to be tested. It will be interesting to determine in future studies whether these 17 putative hyphal genes, whose expression peaks during the S/G2 transition, are part of a mechanism for this pathogenic fungus to 'turn on' hyphal growth late during the cell cycle, or if these genes are used to sustain hyphal growth and ensure that the cell does not transition back to yeast growth. In either case, the involvement of these genes in hyphal growth makes them putative targets for new antifungal drugs aimed at inhibiting hyphae formation in C. albicans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22174285      PMCID: PMC3331874     

Source DB:  PubMed          Journal:  Pac Symp Biocomput        ISSN: 2335-6928


  31 in total

1.  Computational identification of cis-regulatory elements associated with groups of functionally related genes in Saccharomyces cerevisiae.

Authors:  J D Hughes; P W Estep; S Tavazoie; G M Church
Journal:  J Mol Biol       Date:  2000-03-10       Impact factor: 5.469

Review 2.  DNA binding sites: representation and discovery.

Authors:  G D Stormo
Journal:  Bioinformatics       Date:  2000-01       Impact factor: 6.937

3.  Transcription profiling of Candida albicans cells undergoing the yeast-to-hyphal transition.

Authors:  André Nantel; Daniel Dignard; Catherine Bachewich; Doreen Harcus; Anne Marcil; Anne-Pascale Bouin; Christoph W Sensen; Hervé Hogues; Marco van het Hoog; Paul Gordon; Tracey Rigby; François Benoit; Daniel C Tessier; David Y Thomas; Malcolm Whiteway
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

Review 4.  The distinct morphogenic states of Candida albicans.

Authors:  Peter Sudbery; Neil Gow; Judith Berman
Journal:  Trends Microbiol       Date:  2004-07       Impact factor: 17.079

5.  Compact, universal DNA microarrays to comprehensively determine transcription-factor binding site specificities.

Authors:  Michael F Berger; Anthony A Philippakis; Aaron M Qureshi; Fangxue S He; Preston W Estep; Martha L Bulyk
Journal:  Nat Biotechnol       Date:  2006-09-24       Impact factor: 54.908

6.  Hyphal elongation is regulated independently of cell cycle in Candida albicans.

Authors:  Idit Hazan; Marisa Sepulveda-Becerra; Haoping Liu
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

7.  Nonfilamentous C. albicans mutants are avirulent.

Authors:  H J Lo; J R Köhler; B DiDomenico; D Loebenberg; A Cacciapuoti; G R Fink
Journal:  Cell       Date:  1997-09-05       Impact factor: 41.582

8.  Conjugated linoleic acid inhibits hyphal growth in Candida albicans by modulating Ras1p cellular levels and downregulating TEC1 expression.

Authors:  Julie Shareck; André Nantel; Pierre Belhumeur
Journal:  Eukaryot Cell       Date:  2011-02-25

9.  Multiplexed massively parallel SELEX for characterization of human transcription factor binding specificities.

Authors:  Arttu Jolma; Teemu Kivioja; Jarkko Toivonen; Lu Cheng; Gonghong Wei; Martin Enge; Mikko Taipale; Juan M Vaquerizas; Jian Yan; Mikko J Sillanpää; Martin Bonke; Kimmo Palin; Shaheynoor Talukder; Timothy R Hughes; Nicholas M Luscombe; Esko Ukkonen; Jussi Taipale
Journal:  Genome Res       Date:  2010-04-08       Impact factor: 9.043

10.  Gene annotation and drug target discovery in Candida albicans with a tagged transposon mutant collection.

Authors:  Julia Oh; Eula Fung; Ulrich Schlecht; Ronald W Davis; Guri Giaever; Robert P St Onge; Adam Deutschbauer; Corey Nislow
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

View more
  1 in total

1.  Restraining Pathogenicity in Candida albicans by Taxifolin as an Inhibitor of Ras1-pka Pathway.

Authors:  Sonali Mishra; Sangeeta Singh; Krishna Misra
Journal:  Mycopathologia       Date:  2017-07-05       Impact factor: 2.574

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.